EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell functionYusuke Isshiki, Wendy Béguelin|Cancer Cell|2024Cited by 55
EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer modelsPatrizia Porazzi, Marco Ruella, Alberto Carturan et al.|Cancer Cell|2025Cited by 47